---
author: Harvey Guo
created: 2024-02-16 15:48
modified: 2024-02-16 15:48
aliases:
  - Ovarian tumor
share: true
---
# Epidemiology
- Incidence 
	- Second most common gynecological cancer (after endometrial cancer)
	- <span style="background:rgba(240, 200, 0, 0.2)">Incidence increases with age</span>
- Age
	- Peak incidence: 55–64 years of age

---
# Etiology
The most likely pathogenesis of EOC is <span style="background:rgba(240, 200, 0, 0.2)">repeated injury and repair to the ovarian surface, which makes surface epithelial cells susceptible to malignant transformation (ie, acquiring oncogenic mutations).</span>
## Risk factors
- Hormonal factors
	- <span style="background:rgba(240, 200, 0, 0.2)">Elevated number of ovulatory cycles: early menarche and/or late [[menopause|menopause]]</span>
	- <span style="background:rgba(240, 200, 0, 0.2)">Nulliparity</span>
	- [[Endometriosis|Endometriosis]]
## Protective factors
- <span style="background:rgba(240, 200, 0, 0.2)">Combined oral contraceptive pills</span>
- Multiparity
- Breastfeeding
- Bilateral salpingo-oophorectomy
- Bilateral tubal ligation
- Hysterectomy

---
# Pathophysiology


---
# Clinical features
| Histologic type       | Diagnosis                       | Key features                                                                                                                         |
| --------------------- | ------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------ |
| **Epithelial**        | **Serous cystadenocarcinoma**   | Most common ovarian cancer<br>Often bilateral<br>Histology: psammoma bodies                                                          |
|                       | **Mucinous cystadenocarcinoma** | Pseudomyxoma peritonei<br>Mucin-producing epithelial cells                                                                           |
| **Germ cell**         | **Dysgerminoma**                | Adolescents<br>↑ β-hCG, ↑ LDH<br>Histology: "fried-egg" cells                                                                        |
|                       | **Endodermal sinus (yolk sac)** | ↑ AFP<br>Aggressive<br>Schiller-Duval bodies resembling glomeruli                                                                    |
| **Stroma (sex cord)** | **[[Granulosa cell tumor|Granulosa cell tumor]]**    | ↑ Estrogen (e.g., endometrial [[Cellular adaptations\|hyperplasia]], postmenopausal bleeding)<br>↑ Inhibin<br>Histology: Call-Exner bodies, coffee-bean nuclei |
|                       | **Sertoli-Leydig cell tumor**   | <span style="background:rgba(240, 200, 0, 0.2)">↑ Androgens (e.g., hirsutism, clitoromegaly)</span>                                  |


---
# Diagnostics
## [[Tumor markers|Tumor markers]]
- <span style="background:rgba(240, 200, 0, 0.2)">Epithelial ovarian tumors: CA-125 is elevated in ∼ 80% of malignant tumors.</span>
- Germ cell tumors
	- Dysgerminoma: LDH, [[Human chorionic gonadotropin|β-hCG]]
	- [[Testicular tumors|Yolk sac tumor]]: [[Alpha fetoprotein|AFP]]
	- Immature teratoma: [[Alpha fetoprotein|AFP]], LDH, CA-125
	- [[Choriocarcinoma|Choriocarcinoma]]: [[Human chorionic gonadotropin|β-hCG]]
	- Embryonal carcinoma: [[Alpha fetoprotein|AFP]], [[Human chorionic gonadotropin|β-hCG]]
- Sex cord-stromal tumors:
	- [[Granulosa cell tumor|Granulosa cell tumor]]: inhibin

---
# Treatment


---
